Antifibrotic in interstitial lung diseases: When, where, and how long?

被引:4
作者
Rai, Deependra K. [1 ]
Tripathi, Suryakant [2 ]
机构
[1] AIIMS, Dept Pulm Med, Patna, Bihar, India
[2] KJMU, Dept Pulm Med, Lucknow, Uttar Pradesh, India
关键词
IDIOPATHIC PULMONARY-FIBROSIS; FORCED VITAL CAPACITY; DOUBLE-BLIND; PIRFENIDONE; NINTEDANIB; EFFICACY; SAFETY; UPDATE;
D O I
10.4103/lungindia.lungindia_283_22
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:491 / 494
页数:4
相关论文
共 39 条
[1]   Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function [J].
Albera, Carlo ;
Costabel, Ulrich ;
Fagan, Elizabeth A. ;
Glassberg, Marilyn K. ;
Gorina, Eduard ;
Lancaster, Lisa ;
Lederer, David J. ;
Nathan, Steven D. ;
Spirig, Dominique ;
Swigris, Jeff J. .
EUROPEAN RESPIRATORY JOURNAL, 2016, 48 (03) :843-851
[2]  
[Anonymous], Annex 1 summary of product characteristics
[3]   Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial [J].
Behr, Juergen ;
Prasse, Antje ;
Kreuter, Michael ;
Johow, Johannes ;
Rabe, Klaus F. ;
Bonella, Francesco ;
Bonnet, Reiner ;
Grohe, Christian ;
Held, Matthias ;
Wilkens, Heinrike ;
Hammerl, Peter ;
Koschel, Dirk ;
Blaas, Stefan ;
Wirtz, Hubert ;
Ficker, Joachim H. ;
Neumeister, Wolfgang ;
Schoenfeld, Nicolas ;
Claussen, Martin ;
Kneidinger, Nikolaus ;
Frankenberger, Marion ;
Hummler, Simone ;
Kahn, Nicolas ;
Tello, Silke ;
Freise, Julia ;
Welte, Tobias ;
Neuser, Petra ;
Guenther, Andreas .
LANCET RESPIRATORY MEDICINE, 2021, 9 (05) :476-486
[4]   Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases [J].
Cottin, Vincent ;
Richeldi, Luca ;
Rosas, Ivan ;
Otaola, Maria ;
Song, Jin Woo ;
Tomassetti, Sara ;
Wijsenbeek, Marlies ;
Schmitz, Manuela ;
Coeck, Carl ;
Stowasser, Susanne ;
Schlenker-Herceg, Rozsa ;
Kolb, Martin .
RESPIRATORY RESEARCH, 2021, 22 (01)
[5]   Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases [J].
Cottin, Vincent ;
Hirani, Nikhil A. ;
Hotchkin, David L. ;
Nambiar, Anoop M. ;
Ogura, Takashi ;
Otaola, Maria ;
Skowasch, Dirk ;
Park, Jong Sun ;
Poonyagariyagorn, Hataya K. ;
Wuyts, Wim ;
Wells, Athol U. .
EUROPEAN RESPIRATORY REVIEW, 2018, 27 (150)
[6]   Long-term safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis: results from the open-label extension study, INPULSIS-ON [J].
Crestani, Bruno ;
Huggins, John T. ;
Kaye, Mitchell ;
Costabel, Ulrich ;
Glaspole, Ian ;
Ogura, Takashi ;
Song, Jin Woo ;
Stansen, Wibke ;
Quaresma, Manuel ;
Stowasser, Susanne ;
Kreuter, Michael .
LANCET RESPIRATORY MEDICINE, 2019, 7 (01) :60-68
[7]   Nintedanib in Progressive Fibrosing Interstitial Lung Diseases [J].
Flaherty, K. R. ;
Wells, A. U. ;
Cottin, V ;
Devaraj, A. ;
Walsh, S. L. F. ;
Inoue, Y. ;
Richeldi, L. ;
Kolb, M. ;
Tetzlaff, K. ;
Stowasser, S. ;
Coeck, C. ;
Clerisme-Beaty, E. ;
Rosenstock, B. ;
Quaresma, M. ;
Haeufel, T. ;
Goeldner, R-G ;
Schlenker-Herceg, R. ;
Brown, K. K. .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (18) :1718-1727
[8]   Six-month Follow-up Chest CT Findings after Severe COVID-19 Pneumonia [J].
Han, Xiaoyu ;
Fan, Yanqing ;
Alwalid, Osamah ;
Li, Na ;
Jia, Xi ;
Yuan, Mei ;
Li, Yumin ;
Cao, Yukun ;
Gu, Jin ;
Wu, Hanping ;
Shi, Heshui .
RADIOLOGY, 2021, 299 (01) :E177-E186
[9]  
Highland KB, 2021, LANCET RESP MED, V9, P96, DOI 10.1016/S2213-2600(20)30330-1
[10]   A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis [J].
King, Talmadge E., Jr. ;
Bradford, Williamson Z. ;
Castro-Bernardini, Socorro ;
Fagan, Elizabeth A. ;
Glaspole, Ian ;
Glassberg, Marilyn K. ;
Gorina, Eduard ;
Hopkins, Peter M. ;
Kardatzke, David ;
Lancaster, Lisa ;
Lederer, David J. ;
Nathan, Steven D. ;
Pereira, Carlos A. ;
Sahn, Steven A. ;
Sussman, Robert ;
Swigris, Jeffrey J. ;
Noble, Paul W. .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (22) :2083-2092